|--||-- -- / --|
BioLight Life Sciences Ltd. engages in the research, development, and market of pharmaceutical products. It operates through the Ophthalmic and Cancer Diagnostics segments. The Ophthalmic segment distributes topical drugs, surgical systems, and insertable platform under the following brands: Eye-D, IOPtiMate, TeaRx, and OphRx. The Cancer Diagnostics segment provides diagnostic kit and genetic tests which may indicate risks and cancer cells through the CellDetect and BRONJ test. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.
|Suzana Nahum-Zilberberg||Chief Executive Officer|
|Itai Bar-Natan||Chief Financial Officer|
|Yechiel Zvi Yardeni||Internal Auditor|
|Noa Aviram||Secretary & Legal Counsel|